Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
2009 NOV 9 ... choices of FDA-approved products for smoking cessation: varenicline (Chantix™), bupropion (Zyban™), and nicotine in several forms (gums, patches, nasal sprays, inhalers and ...
2009 NOV 23 ... and prescription nicotine-replacement-therapies and two non-nicotine prescription drugs: bupropion and varenicline. According to HHS, counseling should include at least four individual, ...
2009 SEP 28 ... non-responders to escitalopram had better outcomes if they were randomized to switch to bupropion, an antidepressant with a different mechanism of action than escitalopram. ...
2009 NOV 23 ... in remission among within-class, out-of-class or dual-action agents: sertraline (27%), bupropion-sustained release (26%) and venlafaxine-extended release (25%). In step 2 medication ...
2009 NOV 16 ... assigned to one of six treatment groups: nicotine lozenge alone, nicotine patch alone, bupropion alone, patch plus nicotine lozenge, bupropion plus ...
2009 OCT 12 ... Inc. (NASDAQ:OREX) announced that its 24-week, Phase 2b trial for Empatic™ (bupropion SR/zonisamide SR), the Company's second late stage investigational combination drug for ...
2009 OCT 12 ... Inc. (NASDAQ:OREX) announced that its 24-week, Phase 2b trial for Empatic™ (bupropion SR/zonisamide SR), the Company's second late stage investigational combination drug for ...
2009 OCT 19 ... (NRI; desipramine), and the dual dopamine and norepinephrine reuptake inhibitor (bupropion), using the FST in mice. Subactive doses of aripiprazole and antidepressants sertraline, ...
2009 OCT 15 ... the decedent had an elevated level of mirtazapine, an antidepressant, and a low level of bupropion. It was estimated that the subject consumed 1034 g of ethylene glycol," wrote U. Garg ...
2009 OCT 19 ... exist about the optimal length of NRT administration. Co-administration of NRT with bupropion or nortriptyline does not seem to lead to higher abstinence rate than NRT alone." ...
2009 SEP 14 ... 2005 indoor smoking ban on the efficacy of counseling alone or in combination with bupropion for smoking cessation," scientists in Rome, Italy report. "Before and ...
2009 OCT 19 ... in human liver. It catalyzes the oxidative biotransformation of various drugs, including bupropion, which is an antidepressant and a tobacco use cessation agent." "Serious ...
2009 SEP 7 ... Scientists discuss in 'Effects of Ginkgo biloba extract on the pharmacokinetics of bupropion in healthy volunteers' new findings in pharmacokinetics. In this recently published ...
2009 NOV 16 ... sustained-release combination of the dopamine and norepinephrine reuptake antagonist bupropion and the opioid antagonist naltrexone. The proposed dual mechanism of action of the ...
2009 SEP 14 ... gabapentin, which had been prescribed at lower doses in combination with buspirone and bupropion for depression and anxiety. This unusual case of gabapentin dependence and abuse ...
2009 NOV 2 ... Current study results from the report, 'Effects of bupropion augmentation on pro-inflammatory cytokines in escitalopram-resistant patients with major ...
2009 AUG 24 ... the abuse potential of psychostimulants in humans. Bicifadine, cocaine, d-amphetamine, bupropion, and desipramine were evaluated for the production of cocaine-like discriminative ...
2009 SEP 28 ... predict whether subjects were more likely to respond to a different antidepressant, bupropion, also known as Wellbutrin XL. "Until now, other than waiting, there has ...
